Detalhe da pesquisa
1.
Improving Reporter Gene Assay Methodology for Evaluating the Ability of Compounds to Restore P53 Activity.
Int J Mol Sci
; 23(22)2022 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36430341
2.
CS12192, a Novel JAK3/JAK1/TBK1 Inhibitor, Synergistically Enhances the Anti-Inflammation Effect of Methotrexate in a Rat Model of Rheumatoid Arthritis.
Int J Mol Sci
; 23(21)2022 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36362183
3.
Identification of Key Genes and Pathways Associated with Hepatosplenic T-Cell Lymphoma (HSTCL) by Bioinformatics Analysis.
Clin Lab
; 67(5)2021 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33978371
4.
Discovery of Dysimmunity in Large Granular Lymphocytic Leukemia (LGLL) using Bioinformatic Analysis.
Clin Lab
; 67(4)2021 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33865255
5.
A target-triggered biosensing platform for detection of HBV DNA based on DNA walker and CHA.
Anal Biochem
; 554: 16-22, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29856978
6.
Integrating p53-associated genes and infiltrating immune cell characterization as a prognostic biomarker in multiple myeloma.
Heliyon
; 10(8): e30123, 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38699735
7.
Spatial Transcriptomics Analysis Reveals that CCL17 and CCL22 are Robust Indicators of a Suppressive Immune Environment in Angioimmunoblastic T Cell Lymphoma (AITL).
Front Biosci (Landmark Ed)
; 27(9): 270, 2022 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36224014
8.
Comparison of Allogeneic Stem Cell Transplant and Autologous Stem Cell Transplant in Refractory or Relapsed Peripheral T-Cell Lymphoma: A Systematic Review and Meta-analysis.
JAMA Netw Open
; 4(5): e219807, 2021 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34042995
9.
Efficacy and Treatment-Related Adverse Events of Romidepsin in PTCL Clinical Studies: A Systematic Review and Meta-Analysis.
Front Med (Lausanne)
; 8: 732727, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34805202
10.
CXCL1 Clone Evolution Induced by the HDAC Inhibitor Belinostat Might Be a Favorable Prognostic Indicator in Triple-Negative Breast Cancer.
Biomed Res Int
; 2021: 5089371, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33959656